Literature DB >> 2225800

A clinical and demographic profile of a sample of adults with attention deficit hyperactivity disorder, residual state.

W O Shekim1, R F Asarnow, E Hess, K Zaucha, N Wheeler.   

Abstract

It is becoming increasingly recognized that one third to one half of children diagnosed as having attention deficit/hyperactivity disorder (ADHD) continue to exhibit symptoms of the disorder into adulthood. The nature of the clinical picture is not well understood by a substantial number of clinicians. The purpose of this study is to report on the demographic and clinical profile of 56 adults, age 19 to 65 years (48 men, eight women) who present with adult ADHD and meet DSM-III-R criteria for the disorder. Patients underwent a diagnostic work-up consisting of medical and psychiatric evaluation, a structured interview Schedule for Affective Disorders and Schizophrenia-Lifetime Version [SADS-L]), the Symptoms Checklist Revised (SCL-9OR), Conners Attention Deficit Disorder With Hyperactivity (ADDH) scale, structured interview of ADDH, the Global Assessment of Functioning Scale (GAF), and, when available, information from parents was obtained. Ninety-one percent of our sample met the Utah Criteria for adult ADHD. The majority of the sample had additional DSM-III-R diagnoses and only seven had ADHD diagnosis alone. Fifty-three percent of the sample met the criteria for generalized anxiety disorder, 34% alcohol abuse or dependence, 30% drug abuse, 25% dysthymic disorder, and 25% cyclothymic disorder. These findings were similar to those reported in the literature.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2225800     DOI: 10.1016/0010-440x(90)90026-o

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  35 in total

1.  Very early predictors of adolescent depression and suicide attempts in children with attention-deficit/hyperactivity disorder.

Authors:  Andrea Chronis-Tuscano; Brooke S G Molina; William E Pelham; Brooks Applegate; Allison Dahlke; Meghan Overmyer; Benjamin B Lahey
Journal:  Arch Gen Psychiatry       Date:  2010-10

2.  Psychotherapy for the patient with adult ADHD.

Authors:  Julie P Gentile; Rafay Atiq
Journal:  Psychiatry (Edgmont)       Date:  2006-08

3.  Adult ADHD: Diagnosis, Differential Diagnosis, and Medication Management.

Authors:  Julie P Gentile; Rafay Atiq; Paulette M Gillig
Journal:  Psychiatry (Edgmont)       Date:  2006-08

Review 4.  An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults.

Authors:  Timothy E Wilens; Nicholas R Morrison; Jefferson Prince
Journal:  Expert Rev Neurother       Date:  2011-10       Impact factor: 4.618

Review 5.  Psychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD).

Authors:  Esther Sobanski
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-09       Impact factor: 5.270

6.  Dose of Methylphenidate during Service Transition for Adults with ADHD.

Authors:  Marios Adamou; Sara Bowers
Journal:  Ther Adv Psychopharmacol       Date:  2011-06

Review 7.  Attention-deficit/hyperactivity disorder and its comorbidities in women and girls: an evolving picture.

Authors:  Patricia O Quinn
Journal:  Curr Psychiatry Rep       Date:  2008-10       Impact factor: 5.285

Review 8.  Assessment and management of attention-deficit hyperactivity disorder in adults.

Authors:  Margaret Weiss; Candice Murray
Journal:  CMAJ       Date:  2003-03-18       Impact factor: 8.262

9.  [Reliability and validity of the Wender-Utah-Rating-Scale short form. Retrospective assessment of symptoms for attention deficit/hyperactivity disorder].

Authors:  P Retz-Junginger; W Retz; D Blocher; R-D Stieglitz; T Georg; T Supprian; P H Wender; M Rösler
Journal:  Nervenarzt       Date:  2003-11       Impact factor: 1.214

10.  Predictors of diagnostic delay in a clinical sample of French children with attention-deficit/hyperactivity disorder.

Authors:  D Purper-Ouakil; S Cortese; M Wohl; M Asch; E Acquaviva; B Falissard; G Michel; P Gorwood; M C Mouren
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-09-14       Impact factor: 4.785

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.